Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

EXOZYMES INC. (EXOZ) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

EXOZYMES INC. (EXOZ), most recent 12 months reported: net loss $10.19M, free cash flow -$7.14M. Latest balance sheet on file: liquid cash $5.65M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): ELOXX PHARMACEUTICALS, INC. · enGene Therapeutics Inc. · ENTERA BIO LTD. · ESTRELLA IMMUNOPHARMA, INC. · GREEN PLANET BIOENGINEERING CO., LTD. · GREENLAND MINES LTD · Inhibikase Therapeutics, Inc. · IMMUNOVANT, INC.

Stock screener

Watchlist